Prices delayed by at least 15 minutes | Print
Burning Rock Biotech Limited (BNR)
ADS (EACH REPR 1 CLASS A ORD USD0.0002)This share can be held in a Dealing account
Company profile
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer,gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.
Address
Forecast key dates
| Name | Key Date |
|---|---|
| Burning Rock Biotech Ltd Fourth Quarter Earnings Conference Call for 2024 | 2025-03-28T08:00:00 |
| Burning Rock Biotech Ltd Fourth Quarter Earnings Results for 2024 | 2025-03-28T00:00:00 |
| Burning Rock Biotech Ltd Annual General Meeting for 2024 | 2024-12-20T10:00:00 |
| Burning Rock Biotech Ltd Third Quarter Earnings Conference Call for 2024 | 2024-11-29T07:00:00 |
| Burning Rock Biotech Ltd Third Quarter Earnings Results for 2024 | 2024-11-29T00:00:00 |
| Burning Rock Biotech Ltd Second Quarter Earnings Conference Call for 2024 | 2024-08-30T08:00:00 |
| Burning Rock Biotech Ltd Second Quarter Earnings Results for 2024 | 2024-08-30T00:00:00 |
| Burning Rock Biotech Ltd First Quarter Earnings Conference Call for 2024 | 2024-05-30T08:00:00 |
| Burning Rock Biotech Ltd First Quarter Earnings Results for 2024 | 2024-05-30T00:00:00 |
| Burning Rock Biotech Ltd Annual Report for 2023 | 2024-05-03T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Burning Rock Biotech Ltd Fourth Quarter Earnings Conference Call for 2023 | 2024-03-29T08:00:00 |
| Burning Rock Biotech Ltd Fourth Quarter Earnings Result for 2023 | 2024-03-29T00:00:00 |
| Burning Rock Biotech Ltd Annual General Meeting for 2023 | 2023-12-20T10:00:00 |
| Burning Rock Biotech Ltd Third Quarter Earnings Conference Call for 2023 | 2023-11-30T07:00:00 |
| Burning Rock Biotech Ltd Third Quarter Earnings Result for 2023 | 2023-11-30T00:00:00 |
| Burning Rock Biotech Ltd Second Quarter Earnings Conference Call for 2023 | 2023-08-31T08:00:00 |
| Burning Rock Biotech Ltd Second Quarter Earnings Result for 2023 | 2023-08-31T00:00:00 |
| Burning Rock Biotech Ltd First Quarter Earnings Conference Call for 2023 | 2023-05-30T08:00:00 |
| Burning Rock Biotech Ltd First Quarter Earnings Result for 2023 | 2023-05-30T00:00:00 |
| Burning Rock Biotech Ltd Annual Report for 2022 | 2023-04-20T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.